Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-05-20Clinical Trial Update: A Study Evaluating IV Oncaspar® and IV Gemzar® in the Treatment of Solid Tumors and Lymphoma [Phase 1]
A Phase 1 trial evaluated intravenous Oncaspar (pegaspargase) and intravenous Gemzar (gemcitabine) in patients with solid tumors and lymphom…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 [Phase 1]
A Phase I trial studying infusional chemotherapy with the P-glycoprotein antagonist PSC 833 has been completed in patients with several canc…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Phase I Study of Intrathecal Topotecan [Phase 1]
Phase I study evaluating intrathecal topotecan for leukemia, lymphoma, and meningeal neoplasms has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms [Phase 1]
This is a Phase I trial update evaluating continuous infusion of UCN-01 in patients with refractory neoplasms, with the study status indicat…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma [Phase 1]
Phase 1 feasibility study evaluating interleukin-1 alpha in combination with Ifosfamide, Carboplatin, and Etoposide with autologous bone mar…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating HLA-mismatched peripheral blood stem cell transplantation for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer [Phase 1]
A completed Phase I study of oral COL-3 (NSC-683551), an matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer, …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 [Phase 1]
Phase I study of infusional paclitaxel combined with the P-glycoprotein antagonist PSC 833 (valspodar) in patients with various cancers; the…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
A completed clinical trial update detailing in vitro investigations of immunological and stem cell function in peripheral blood mononuclear …
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies
This is a National Cancer Institute clinical trial update describing the collection of peripheral blood lymphocytes and marrow progenitor ce…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Evaluation and Natural History of Children With Cancer and AIDS
A National Cancer Institute study update describing the evaluation and natural history of cancer in children with AIDS/HIV infection; the st…
-
CLINICAL_TRIALS trial_result · 2008-02-28Clinical Trial Update: Pegfilgrastim PBPC Mobilization Study [Phase 2]
Completed Phase 2 clinical trial sponsored by Amgen evaluating pegfilgrastim for peripheral blood progenitor cell mobilization in patients w…
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor [Phase 2]
Phase 2 clinical trial evaluating tacrolimus and mycophenolate mofetil as post-grafting immunosuppression after conditioning with Flu TBI in…
-
CLINICAL_TRIALS research · 2007-11-20Clinical Trial Update: Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma [Phase 2]
A Phase 2 clinical trial investigating a biweekly combination of gemcitabine, oxaliplatin, and dexamethasone for relapsed/refractory maligna…
-
CLINICAL_TRIALS trial_result · 2007-11-01Clinical Trial Update: Treatment of Disseminated High Grade Lymphoma [Phase 2, Phase 3]
This clinical trial update summarizes the completion of Phase 2 and Phase 3 studies evaluating treatment for disseminated high-grade lymphom…
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma [Phase 3]
A Phase 3 trial comparing safety and efficacy of piperacillin/tazobactam versus cefepime in patients with hematologic neoplasms or lymphoma …
-
CLINICAL_TRIALS trial_result · 2007-09-11Clinical Trial Update: Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component) [Phase 1]
A Phase 1 study of CS-1008 in patients with advanced solid malignancies and lymphomas (without leukemic components) has completed.
-
CLINICAL_TRIALS trial_result · 2007-08-17Clinical Trial Update: Dose-Dense Therapy in Aggressive Lymphoma
Clinical trial update indicates the dose-dense therapy study for aggressive lymphoma is no longer available.
-
CLINICAL_TRIALS trial_result · 2007-06-14Clinical Trial Update: Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia [Phase 1]
A Phase 1 study evaluating MEDI-507 in CD2-positive lymphoma and leukemia has been terminated.
-
CLINICAL_TRIALS research · 2007-04-27Clinical Trial Update: Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study [NA]
This entry describes a randomized medico-economic study investigating whether remission evaluation by FDG-PET influences subsequent treatmen…
-
CLINICAL_TRIALS trial_result · 2007-04-24Clinical Trial Update: Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. [Phase 1]
Phase 1 safety trial evaluating parathyroid hormone for stem cell mobilization in patients with lymphoma, multiple myeloma, or acute myeloid…
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: Dose Reduction in Thoracic CT [Phase 1]
This entry reports the completion of a Phase 1 trial evaluating dose reduction in thoracic CT for lymphoma patients.
-
CLINICAL_TRIALS research · 2007-03-26Clinical Trial Update: Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation [Phase 3]
A Phase 3 clinical trial update from Technische Universität Dresden evaluates Helicobacter eradication followed by radiation therapy for lym…
-
CLINICAL_TRIALS trial_result · 2006-11-09Clinical Trial Update: Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia [Phase 3]
A Phase 3 trial by Pfizer evaluated the safety and efficacy of PN-152,243 and PN-196,444 to prevent thrombocytopenia in cancer patients; the…
-
CLINICAL_TRIALS trial_result · 2006-07-17Clinical Trial Update: A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors [Phase 1]
This is a completed Phase I trial evaluating the safety of combining 5-fluorouracil with GW776 and low-dose leucovorin in adults with solid …